Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $35.6500 (-2.33%) ($35.6500 - $36.4600) on Fri. Apr. 14, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.8% (three month average) | RSI | 59 | Latest Price | $35.6500(-2.33%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -1.5% a day on average for past five trading days. | Weekly Trend | HALO declines -0.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IFRA(38%) XBI(37%) IBB(36%) IWO(36%) IWM(34%) | Factors Impacting HALO price | HALO will decline at least -1.4% in a week (0% probabilities). VXX(-14%) UUP(-14%) VIXM(-9%) TBT(-9%) UNG(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.4% (StdDev 2.8%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
Resistance Level | $36.26 | 5 Day Moving Average | $36.4(-2.06%) | 10 Day Moving Average | $37.15(-4.04%) | 20 Day Moving Average | $36.26(-1.68%) | To recent high | -33.1% | To recent low | 8.6% | Market Cap | $4.872b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |